Abstract
The achievable concentrations of 1-(4-amino-2-methyl-5-pyrimidinyl)methyl-3-(2-chloroethyl-3-nitrosourea (ACNU), adriamycin, mitomycin C, vindesine, and epipodophyllotoxin suppressed the natural killer (NK) activity of human peripheral blood lymphocytes in vitro, whereas NK activity was not decreased 24 h after incubation with the maximum achievable concentration of cisplatin (cDDP). NK activity of patients treated with 80 mg per square meter of cDDP alone was not decreased for 3 weeks after cDDP administration. In contrast, NK activity of patients treated with the same dose of cDDP and methylprednisolone was significantly decreased 1 week after cDDP administration. It was concluded that methylprednisolone, used as an antiemetic agent, had an immunosuppressive effect.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
Antineoplastic Agents / administration & dosage
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Cisplatin / therapeutic use*
-
Cytotoxicity Tests, Immunologic
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Female
-
Humans
-
Immune Tolerance / drug effects*
-
In Vitro Techniques
-
Killer Cells, Natural / drug effects*
-
Killer Cells, Natural / immunology
-
Lung Neoplasms / drug therapy
-
Lung Neoplasms / immunology*
-
Male
-
Mediastinal Neoplasms / drug therapy
-
Mediastinal Neoplasms / immunology*
-
Methylprednisolone / therapeutic use*
-
Middle Aged
-
Mitomycin
-
Mitomycins / administration & dosage
-
Nimustine
-
Nitrosourea Compounds / administration & dosage
-
Vinblastine / administration & dosage
-
Vinblastine / analogs & derivatives
-
Vindesine
Substances
-
Antineoplastic Agents
-
Mitomycins
-
Nitrosourea Compounds
-
Nimustine
-
Mitomycin
-
Vinblastine
-
Etoposide
-
Doxorubicin
-
Cisplatin
-
Vindesine
-
Methylprednisolone